Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-22+30,000→ 30,000 totalExercise: $3.68Exp: 2034-02-21→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date.